Another target within the top-10 was Integrin Subunit Beta7 (ITGB7), an oncogenic adhesion molecule, also known to enhance MM cell adhesion to bone-marrow stroma, migration, and invasion (Neri et al. 2011, Roy Choudhury et al. 2023). Here, ITGB7 is linked to Miyoshi myopathy.